More on IRWD
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.63 |
|
|||
| Open | $3.63 | ||||
| 52 Wk High | $16.89 | ||||
| 52 Wk Low | $7.35 | ||||
| Day High | $3.63 | ||||
| Day Low | $3.63 | ||||
| P/E | N/A | ||||
| EPS | $-2.35 | ||||
| Volume | 6,774 | ||||
- Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
- FDA approves LINZESS for children ages 2-5 with functional constipation
- FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)
- Form 8-K/A IRONWOOD PHARMACEUTICALS For: May 08
- Form 4 IRONWOOD PHARMACEUTICALS For: May 19 Filed by: Silver Ronald
- Form SCHEDULE 13G/A IRONWOOD PHARMACEUTICALS Filed by: ARMISTICE CAPITAL, LLC
- Form SCHEDULE 13G/A IRONWOOD PHARMACEUTICALS Filed by: RENAISSANCE TECHNOLOGIES LLC
- Form 8-K IRONWOOD PHARMACEUTICALS For: May 08
- Form 10-Q IRONWOOD PHARMACEUTICALS For: Mar 31
- Ironwood Pharma (IRWD) Tops Q1 EPS by 5c, provides guidance
Entities mentioned with IRWD
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- Definitive Agreement | View Related Stories »
- JPMorgan | View Related Stories »
- Morgan Stanley | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
